Xavier Mariette

Risk of tuberculosis is higher with anti–tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three‐year prospective french research axed on tolerance of biotherapies registry

Florence Tubach, Dominique Salmon, Philippe Ravaud et al. · Arthritis & Rheumatism · 2009 · 628 citations · Full text

2021 DORIS definition of remission in SLE: final recommendations from an international task force

Ronald van Vollenhoven, George Βertsias, Andrea Doria et al. · Lupus Science & Medicine · 2021 · 299 citations · Full text

Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity

Jérémie Sellam, Valérie Proulle, Astrid Jüngel et al. · Arthritis Research & Therapy · 2009 · 235 citations · Full text

Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production

F. Lavie, Corinne Miceli‐Richard, Marc Ittah et al. · Annals of the Rheumatic Diseases · 2006 · 195 citations · Full text

CD4 CD25high regulatory T cells are not impaired in patients with primary Sjögren's syndrome

J.-E. Gottenberg, F. Lavie, Karim Abbed et al. · Journal of Autoimmunity · 2005 · 146 citations